Through the fund
Direct to Moderna
Both paths
trace how much of the same catalyst arrives in your account
Why the genomics ETF cannot deliver concentrated V940 or Moderna exposure
V940 catalyst
mRNA vaccine event
fund path
direct path
MRNA equity
concentrated, binary
concentrated stream
ARKG basket
~33-34 holdings
top-10 names — ~60% of assets
10x
Tempus
Twist
CRISPR
AbSci
+5
top-10 line
MRNA
below top-10
tools
diagnostics
enablers
~20 more
indirect readthrough only
fee on basket
fund fee and rebalance on the whole basket
full
diluted level
your account
the two vehicles are not substitutes for the catalyst